Physician profile
Michael Read
NPI 1649808866
$8,087.57
in general payments reported to CMS, 2019-2025
11 companies · $1,318 in 2025
The $1,318 reported for 2025 was more than what 91% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,015 · 2022: $1,587 · 2023: $527 · 2024: $641 · 2025: $1,318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,450 · Travel and Lodging: $1,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,450.17 |
| Travel and Lodging | $1,034.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cgg Medical INC | $4,015.00 | 2021-2024 | |
| Medical Device Business Services, INC. | $1,317.97 | 2025 | Na |
| Evolution Surgical, INC | $1,226.86 | 2021 | |
| Stryker Corporation | $810.40 | 2022-2024 | T2 Alpha, Mako, Gmrs |
| Medtronic, INC. | $272.61 | 2021-2023 | Unid_pass |
| Arthrex, INC. | $131.90 | 2024 | |
| Acelrx Pharmaceuticals, INC. | $120.02 | 2021 | |
| Endo Pharmaceuticals INC. | $95.25 | 2023 | Xiaflex |
| Linvatec Corporation | $44.12 | 2021 | |
| Depuy Synthes Sales INC. | $34.72 | 2024 | Na |
| Ethicon US, LLC | $18.72 | 2024 | Stratafix, Vistaseal, Ethicon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Read listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.